Avera raises $48M

Avera (San Diego, Calif.) raised $48 million in a series C round led by Perseus-Soros BioPharmaceutical. Other investors in the autoimmune and neurology company included Schroder Ventures; Aberdare Ventures; BioAsia Investments; H.I.G. Ventures; Montreux Equity; Bay City Capital; BTG (LSE:BTG); Frazier Healthcare; InterWest; St. Paul Venture; and Windamere Venture. Steven Elms, managing director of Perseus-Soros BioPharmaceutical, and Lutz Giebel, venture partner at Schroder Ventures, will join Avera's board. ...